Tilray and Aphria logos
Source: Tilray Facebook, Aphria Facebook

Latest Tilray and Aphria Merger News: Is It a Done Deal?

By

Apr. 19 2021, Updated 9:21 a.m. ET

In December 2020, Tilray (TLRY) and Aphria (APHA) announced a merger that would create the world’s largest marijuana company. Last week, Aphria stockholders approved the deal overwhelmingly. However, the meeting of Tilray stockholders was postponed. What’s happening with the Tilray and Aphria merger? Why is it delayed and has it been confirmed?

Article continues below advertisement

Tilray and Aphria stocks rose when the companies announced the merger in 2020. The stocks continued to rise in 2021 after the Senate runoff. However, since then, both TLRY and APHA have fallen sharply amid the sell-off in marijuana stocks.

Tilray and Aphria merger details

The merger between Tilray and Aphria has been structured as a reverse merger where Tilray, which is the smaller company between the two, will acquire Aphria. Aphria stockholders will get 0.8381 Tilray shares for each APHA share that they hold. 

Article continues below advertisement

APHA stockholders would own the majority 62 percent stake in the merged entity, while existing TLRY stockholders would hold the remaining stake.

Article continues below advertisement

Aphria CEO Irwin D. Simon would lead the new company in a dual role as CEO and chairman, while Tilray CEO Brendan Kennedy would be a director on the board. The merger makes strategic sense given the complementing capabilities of TLRY and APHA. Also, there are financial synergies involved. Finally, consolidation is a welcome step in the marijuana industry.

Tilray and Aphria merger hasn't been confirmed

The Tilray and Aphria merger has received regulatory approvals and APHA stockholders have also confirmed the merger. However, for the merger to be confirmed, it would have to be approved by TLRY stockholders.

Article continues below advertisement

TLRY and APHA merger got delayed

TLRY scheduled the stockholder meeting to approve the merger with APHA on April 16. However, the company moved the meeting to April 30. Interestingly, it also amended the bylaws and said that the quorum requirement for the stockholder meeting would be one-third of the voting power. Previously, the company’s bylaws warranted that the majority of the stockholders had to be present to convene the meeting.

Article continues below advertisement

Is the Tilray and Aphria merger a done deal?

The delayed merger vote and the new quorum requirements have raised concerns. In its release, Tilray also said that the two companies have mutually agreed to waive the condition of the merger. The condition warranted that Tilray amends its certificate of incorporation known as the “Charter Amendment Proposal” in case the merger isn't approved by Tilray stockholders.

Article continues below advertisement

Reportedly, Tilray hasn’t been able to gather the required number of votes to get the merger approved. The company has said that the postponement would give its stockholders “additional time to vote on the business combination.” Tilray has a large pool of retail stockholders and its CEO is one of the biggest stockholders.

Buying TLRY or APHA stock

As I noted previously, as a standalone company, APHA looks better placed compared to TLRY given its better financials and lower comparative valuation. Incidentally, there was a massive merger arbitrage in the TLRY and APHA merger.

Article continues below advertisement
tlry apha merger valuation
Source: Koyfin

Tilray versus Aphria NTM PS multiple

However, the arbitrage opportunity has since come down greatly. Based on April 16 closing prices, APHA trades at 0.822x of what TLRY trades at, which is similar to the merger ratio. As I had noted previously, the massive arbitrage wasn't sustainable. TLRY was trading at almost twice what it should have based on the merger ratio.

The steep fall in TLRY stock from the peaks ensured that the arbitrage evaporated. Now, all eyes will be on the TLRY stockholder meeting later this month when the company takes up the merger vote.

Advertisement

More From Market Realist

  • Marijuana plant
    Cannabis
    What the Tilray and Aphria Merger Means for Investors
  • Person buying medical marijuana from a pharmacy
    Cannabis
    Sundial Growers Wants to Be the Berkshire Hathaway of Marijuana
  • Tilray sign
    Cannabis
    Tilray Stock Is Expected to Fall After Aphria Merger Date
  • Marijuana field and Aphria logo
    Cannabis
    Why Aphria Looks Like a Good Buy Before the Tilray Merger
  • CONNECT with Market Realist
  • Link to Facebook
  • Link to Twitter
  • Link to Instagram
  • Link to Email Subscribe
Market Realist Logo
Do Not Sell My Personal Information

© Copyright 2021 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.